Wells Fargo & Company Biogen Inc. Put Options Transaction History

Wells Fargo & Company

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $4.79 Million - $5.4 Million	18,900 New	18,900 $4.86 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $1.05 Million - $1.2 Million	4,100 New	4,100 $1.14 Million
Q1 2021 May 13, 2021	BUY	$242.95 - $284.63 $1.94 Million - $2.28 Million	8,000 New	8,000 $2.24 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.